CeriBell
Update in progressCBLL (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
CeriBell, Inc. is a U.S. medical technology company developing the Ceribell System, a point‑of‑care EEG platform for acute care patients. It offers disposable headbands and headcaps, a pocket‑sized rechargeable recorder for wireless EEG transmission, and Clarity, an AI seizure detection algorithm. The firm also operates an EEG portal for real-time remote data access. Formerly Brain Stethoscope, Inc., renamed in 2015; founded in 2014 and based in Sunnyvale, California.
Company score
- Sentiment
- 0.54
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.49
- Governance
- 0.10
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.17
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.35
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGS (NMS)
- LocationUnited States
- CEODr. Xingjuan Chao Ph.D.
- Founded2014
- Employees327
- Websitewww.ceribell.com
Identifiers
- ISINUS15678C1027
- FIGIBBG00KMSVGN4
- CUSIP15678C102
- CIK0001861107